Post

New research · Ophthalmology
Cancers · 15h
Cohort studyCancers · 2025

Vitreoretinal Surgery for Intraocular Complications Following Radiotherapy Treatment of Uveal Melanoma.

Thomas Joseph Padley, Rumana Hussain, Antonio Eleuteri … Heinrich Heimann
Read paper
OphthalmologyCohort study

Only 13% of eyes gained ≥3 lines of vision after vitrectomy for radiotherapy complications

Vitreoretinal Surgery for Intraocular Complications Following Radiotherapy Treatment of Uveal Melanoma.

Thomas Joseph Padley … Heinrich Heimann
Cancers · 2025
Background

Globe-sparing radiotherapy is widely utilised in the treatment of uveal melanoma, but often results in complications requiring vitreoretinal intervention.

Methods

We reviewed 1794 patients treated with radiotherapy for uveal melanoma between 2012 and 2022.

n = 1794 patients
13%
Results
13%
very few eyes saw meaningful vision recovery after this surgery
n = 1794 patients
More results

Complications requiring vitrectomy were more common after proton-beam radiotherapy than plaque brachytherapy (5.4% versus 3.0%).

Common indications included vitreous haemorrhage (39%) and retinal detachment/toxic tumour syndrome (31%).

The affected tumours were larger, more often ciliary body in origin, and associated with a worse prognosis.

More results

Proton-beam patients had worse outcomes than plaque brachytherapy patients.

“
Conclusion · 1 of 2

Vitreoretinal complications after uveal melanoma radiotherapy are rare, but timely treatment by those with experience may enable patients to keep their eye in situations where enucleation would be the only alternative.

Conclusion · 2 of 2

Patients and clinicians must understand the risks of complications to make informed decisions about treatment plans, with vitreoretinal surgeons and ocular oncologists key to outcomes.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement
Cohort Study
86.7%
of infants probed after 12 months still had unresolved tear duct blockage
Observational
16%
eyelid tissue in rosacea patients showed less of this key repair-signaling protein inside cell nuclei
Cohort Study
25%
about 1 in 4 treated cases had symptoms return after improving